VIMOVO

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Tersedia dari:

ASTRA ZENECA ISRAEL LTD

Kode ATC:

G02CC02

Bentuk farmasi:

TABLETS MODIFIED RELEASE

Rute administrasi :

PER OS

Diproduksi oleh:

ASTRA ZENECA AB., SWEDEN

Kelompok Terapi:

NAPROXEN

Indikasi Terapi:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Tanggal Otorisasi:

2011-12-01